Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for metabolic research applications. This compound demonstrates superior efficacy in glucose control studies compared to selective GLP-1 receptor agonists.
The white lyophilized powder formulation offers excellent stability and solubility characteristics for laboratory use. Our GMP-certified production facility ensures batch-to-batch consistency and purity exceeding 99%.
Research applications include studies of glucose metabolism, insulin secretion mechanisms, and weight management pathways. The compound has shown potential in preclinical models for improving metabolic parameters through dual receptor activation.
When you buy tirzepatide from our facility, you receive pharmaceutical-grade material with complete analytical documentation including HPLC purity reports, mass spectrometry verification, and endotoxin testing results. Custom formulations and bulk quantities are available for research institutions.
Storage recommendations include maintaining the lyophilized powder at -20°C for long-term stability. Reconstituted solutions should be used immediately or stored at 2-8°C for short-term use. Proper handling procedures should be followed for all research materials.
This product is intended for laboratory research use only. Not for human consumption. Researchers should consult all applicable regulations before purchasing tirzepatide for scientific studies.